Cost-benefit analysis of total PSA, free/total PSA and complexed PSA for prostate cancer screening

被引：0
|
作者：
Ellison, L
Bright, S
Veltri, R
Cheli, C
Partin, A
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [1] Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection
    Tanguay, S
    Bégin, LR
    Elhilali, MM
    Behlouli, H
    Karakiewicz, PI
    Aprikian, AG
    [J]. UROLOGY, 2002, 59 (02) : 261 - 265
  • [2] Complexed PSA and Total PSA in patients with Benign Prostate Hyperplasia and Prostate Cancer
    Tamimi, W.
    Dafterdar, R.
    Mansi, M.
    Alsaad, K.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (06) : A111 - A111
  • [3] Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
    F. Strittmatter
    P. Stieber
    D. Nagel
    C. Füllhase
    S. Walther
    C. G. Stief
    R. Waidelich
    [J]. European Journal of Medical Research, 16
  • [4] DETECTION OF PROSTATE CANCER WITH COMPLEXED PSA AND COMPLEXED/TOTAL PSA RATIO - IS THERE ANY ADVANTAGE?
    Strittmatter, F.
    Stieber, P.
    Nagel, D.
    Fuellhase, C.
    Walther, S.
    Stief, C. G.
    Waidelich, R.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 (10) : 445 - 450
  • [5] Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when?
    Basso, D
    Fogar, P
    Piva, MG
    Navaglia, F
    Mazza, S
    Prayer-Galetti, T
    Castellucci, E
    Pagano, F
    Plebani, M
    [J]. UROLOGY, 2000, 55 (05) : 710 - 715
  • [6] RELATION BETWEEN SERUM LEVEL OF TOTAL PSA AND FREE PSA/TOTAL PSA RATIO WITH GRADE OF PROSTATE CANCER
    Yazdani, Mohammad
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A217 - A217
  • [7] Afssaps market survey of total PSA, free PSA and complexed PSA assay kits
    [J]. PROGRES EN UROLOGIE, 2007, 17 (02): : 176 - 176
  • [8] Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels
    Reissigl, A
    Klocker, H
    Pointner, J
    Ennemoser, O
    Falk, M
    Bartsch, G
    [J]. PROSTATE, 1997, 30 (04): : 243 - 247
  • [9] Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening
    Ellison, L
    Cheli, CD
    Bright, S
    Veltri, RW
    Partin, AW
    [J]. UROLOGY, 2002, 60 (4A) : 42 - 46
  • [10] Progress in standardization and quality assessment of free PSA (prostate specific antigen), total PSA, and complexed PSA immunoassay's
    Nakamura, RM
    Abrahamsson, PA
    Chopin, D
    Elgamal, AA
    Neel, H
    Stenman, H
    Eschenbach, AV
    Wu, JT
    Zhou, ZQ
    [J]. PROSTATE CANCER, 2000, : 203 - 217
12345